id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-0271-0003,FDA,FDA-2014-E-0271,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2014-05-27T04:00:00Z,2014,5,2014-05-27T04:00:00Z,,2014-05-27T12:55:39Z,,0,0,0900006481715539
FDA-2014-E-0271-0001,FDA,FDA-2014-E-0271,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2014-03-06T05:00:00Z,2014,3,2014-03-06T05:00:00Z,,2014-03-06T13:06:02Z,,0,0,09000064815fd1b3
FDA-2014-E-0271-0002,FDA,FDA-2014-E-0271,"Patent Extension from Second Sight Medical Products, Inc.",Other,Application,2014-03-06T05:00:00Z,2014,3,2014-03-06T05:00:00Z,,2014-03-06T13:09:30Z,,0,0,09000064815fd1b2